VIDEO: SCS microinjector offers reliable option for suprachoroidal delivery
In this Healio Video Perspective, Mathew W. MacCumber, MD, PhD, discusses his poster presentation from the Retina Society meeting exploring the clinical use of the SCS microinjector for suprachoroidal delivery.
“SCS injection with the SCS microinjector is an innovative procedure that can reliably deliver injectate to the suprachoroidal space, has an acceptable safety profile in clinical trials and has the potential for broad adoption in clinical practice, initially for triamcinolone acetonide, but I imagine, in the future, for other therapeutics,” MacCumber said.
Collapse
MacCumber MW, et al. Suprachoroidal delivery with the SCS microinjector: Biomechanics and clinical use. Presented at: Retina Society meeting; Nov. 2-5, 2022; Pasadena, California.
Read more about